Urology
Volume 76, Issue 2 , Pages 515.e15-515.e20 , August 2010

In Vitro Multicompartmental Bladder Model for Assessing Blockage of Urinary Catheters: Effect of Hydrogel Coating on Dynamics of Proteus mirabilis Growth

  • Katarzyna A. Kazmierska

      Affiliations

    • Faculty of Chemical and Process Engineering, Warsaw University of Technology, Warsaw, Poland
    • Corresponding Author InformationReprint requests: Katarzyna Kazmierska, M.Sc., Warsaw University of Technology, Faculty of Chemical and Process Engineering, ul. Warynskiego 1, 00-645 Warsaw, Poland
  • ,
  • Richard Thompson

      Affiliations

    • Biomed Centre, Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom
  • ,
  • Nicola Morris

      Affiliations

    • Biomed Centre, Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom
  • ,
  • Adele Long

      Affiliations

    • Biomed Centre, Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom
  • ,
  • Tomasz Ciach

      Affiliations

    • Faculty of Chemical and Process Engineering, Warsaw University of Technology, Warsaw, Poland

Received 5 January 2010 ,Accepted 21 April 2010.

References 

  1. Kunin CM. Urinary Tract Infections: Detection, Prevention and management. In: 4th ed.. Philadelphia: Lea & Febiger; 1987;p. 248–251
  2. Billote-Domingo K, Mendoza MT, Torres TT. Catheter-related urinary tract infections: incidence, risk factors and microbiologic profile. Phil J Microbiol Infect Dis. 1999;28:133–138
  3. Burke JP, Yeo TW. Nosocomial urinary tract infections. In:  Mayhall CG editors. Hospital Epidemiology and Infection Control. 3rd ed.. Philadelphia: Lippincott Williams & Wilkins; 2004;p. 267–286
  4. Stickler DJ, Zimakoff J. Complications of urinary tract infections associated with devices used for long-term bladder management. J Hosp Infect. 1994;28:177–194
  5. Stickler DJ, Young R, Jones G, et al. Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm?. Urol Res. 2003;31:306–311
  6. Morris NS, Stickler DJ. The effect of urease inhibitors on the encrustation of urethral catheters. Urol Res. 1998;26:275–279
  7. Kunin CM. Nosocomial urinary tract infections and the indwelling catheter: what is new and what is true?. Chest. 2001;120:10–12
  8. Saint S, Meddings JA, Calfee D, et al. Catheter-associated urinary tract infection and the Medicare rule changes. Ann Intern Med. 2009;150:877–884
  9. Madeo M, Roodhouse AJ. Reducing the risk associated with urinary catheters. Nurs Stand. 2009;23:47–55
  10. Kazmierska K, Szwast M, Ciach T. Determination of urethral catheter surface lubricity. J Mater Sci Mater Med. 2008;19:2301–2306
  11. Mistry S, Goldfarb D, Roth DR. Use of hydrophilic-coated urethral catheters in management of acute urinary retention. Urology. 2007;70:25–27
  12. Sabbuba N, Hughes G, Stickler DJ. The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int. 2002;89:55–60
  13. Johnson JR, Kuskowski MA, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med. 2006;144:116–126
  14. Mulder G, Carvorsi J, Lee D. Polyhexamethylene biguanide (PHMB): an addendum to current topical antimicrobials. Wounds. 2007;19:173–182
  15. Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg. 1986;151:400–406
  16. Kristinsson KG, Jansen B, Treitz U, et al. Antimicrobial activity of polymers coated with iodine-complexed polyvinylpyrrolidone. J Biomater Appl. 1991;5:173–184
  17. Bhargava HN, Leonard PA. Triclosan: applications and safety. Am J Infect Control. 1996;24:209–218
  18. Levy CW, Roujeinikova A, Sedelnikova S, et al. Molecular basis of triclosan activity. Nature. 1999;398:383–384
  19. Fiss EM, Rule KL, Vikesland PJ. Formation of chloroform and other chlorinated byproducts by chlorination of triclosan-containing antibacterial products. Environ Sci Technol. 2007;41:2387–2394
  20. Jones GLl, Russell AD, Caliskan Z, et al. A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan. Eur Urol. 2005;48:838–845
  21. Jones GLl, Muller CT, O'Reilly M, et al. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters. J Antimicrob Chemother. 2006;57:266–272
  22. Stickler DJ, Jones GL, Russell AD. Control of encrustation and blockage of Foley catheters. Lancet. 2003;361:1435–1437
  23. Williams GJ, Stickler DJ. Effect of triclosan on the formation of crystalline biofilms by mixed communities of urinary tract pathogens on urinary catheters. J Med Microbiol. 2008;57:1135–1140
  24. Cadieux PA, Chew BH, Nott L, et al. Use of triclosan-eluting ureteral stents in patients with long-term stents. J Endourol. 2009;23:1187–1194
  25. Elwood CN, Lange D, Nadeau R, et al. Novel in vitro model for studying ureteric stent-induced cell injury. BJU Int. 2010;105:1318–1323
  26. Kazmierska KA, Kuc K, Ciach T. Polyvinylpyrrolidone-polyurethane interpolymer hydrogel coating as a local drug delivery system. Acta Pol Pharm. 2008;65:763–766
  27. Stickler DJ, Morris NS, Winters C. Simple physical model to study formation and physiology of biofilms on urethral catheters. Methods Enzymol. 1999;310:494–501
  28. Band LR, Cummings LJ, Waters SL, et al. Modelling crystal aggregation and deposition in the catheterised lower urinary tract. J Math Biol. 2009;59:809–840
  29. Micklus MJ, Ou-Yang DT. Coated substrate having a low coefficient of friction: hydrophilic coating and a method of making the same. US Patent 1978; No. 4100309.
  30. Griffith DP, Musher DM, Itin C. Urease: the preliminary cause of infection-induced urinary stones. Invest Urol. 1976;13:346–350

 The work of K. Kazmierska was supported by the European Union in the framework of the European Social Fund through the Warsaw University of Technology Development Programme and Research Project of Polish Ministry of Science and Higher Education.

PII: S0090-4295(10)00608-4

doi: 10.1016/j.urology.2010.04.039

Urology
Volume 76, Issue 2 , Pages 515.e15-515.e20 , August 2010